Neurophysiological Characteristics in Type II and Type III 5q Spinal Muscular Atrophy Patients: Impact of Nusinersen Treatment

Li D, Sun N, Xiang L, Liu J, Wang X, Yang L, Huang S

Drug Design, Development and Therapy 2024, 18:953-965

Published Date: 28 March 2024